RxDoctor Payments Data

Celeste Vickery, DO

Family Medicine · Orange City, FLNPI 1780211821

Payments from drug & device makers

$522in general payments, 2019–2025

Across 27 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$255
  • Novo Nordisk$64
  • Amgen$42
  • Bayer$35
  • Lilly USA, LLC$29
  • Boston Scientific$25
  • plus $72 from 4 others

What the payments were for

  • Food & beverage$522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$522 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$71,430
Medicare patients
136
Services billed
1,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$74,817
OzempicSemaglutide55$58,364
RybelsusSemaglutide23$48,832
JardianceEmpagliflozin37$35,293
JanuviaSitagliptin Phosphate17$25,828
Tresiba Flextouch U-100Insulin Degludec11$14,426
SymbicortBudesonide/Formoterol Fumarate16$4,286
Gabapentin95$1,783
Atorvastatin Calcium197$1,495
Levothyroxine Sodium121$1,058
Rosuvastatin Calcium73$1,023
Losartan Potassium86$889
Ventolin HfaAlbuterol Sulfate16$869
Metoprolol Succinate54$778
Omeprazole46$740

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$64$107,19678 claims
Lilly USA, LLCMounjaro$29$74,81762 claims
MerckJanuvia$13$25,82817 claims
AstraZenecaSymbicort$19$4,28616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orange City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →